clinical-usefulness, convenience and cost in order to adopt them. Unsurprisingly, concerns have been raised by laboratory professionals about the decentralisation of hospital testing and by doctors about patient and consumer self-testing. In both cases, there is concern that the use of POC products by less skilled users may result in inaccurate diagnoses, leading to resistance to the changes needed for POC products to be widely implemented.
Overcoming these issues will be critical to the POC diagnostic sector if it is to realise its full potential – at present, adoption and usage rates vary widely, and there remains much untapped potential in the worldwide market.
Innovation is making an impact
There is currently much innovation in the market. Products that enable multi-parameter diagnostics using technologies such as microfluidics are a major focus, as are products for personalised medicine. For example, the first POC DNA analysis system, Spartan Bioscience's RX CYP2C19, has European approval to help identify patients with impaired metabolism to the popular anti-blood clotting medication, clopidogrel.
This new September 2012 report delivers a complete and insightful analysis
This new 130-page highly detailed report – Volume 1 of a 4-volume study of the whole IVD sector to be published this autumn/winter – provides executives with a complete understanding of the issues which are shaping the market and how they will affect its commercial development.
Get the best from your investment! Pdf or print formats and the brilliant Espicom Interactive included at no extra cost! Customers can choose print or pdf format but all get access via Espicom Interactive. Customers will really benefit from accessing this report's rich content through Espicom Interactive by... Page: 1 2 3 4 5 6 7 8 9 10 Related medicine technology :1
Accessing daily-reviewed company reports, updates and news
Intuitively cross file searching and getting fast results
Saving time and ef
. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology2
. Leading Cardiology Experts Advice on Dietary Supplement Niacins: Make Informed Choices at the Shelf and Scan the Label for Nicotinic Acid3
. Philips and Corindus announce distribution agreement to sell Corindus robotic-assisted interventional cardiology system in the United States4
. Brazil Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others5
. North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others6
. 50% of U.S. News & World Reports "Best Hospitals" for Cardiology & Heart Surgery Making the SynCardia Total Artificial Heart Part of Their Toolbox7
. Aequus BioPharma Appoints Ronald J. Berenson, M.D. President and CEO8
. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint9
. AAIPharma Appoints Senior Director of Biopharmaceutical Development10
. uniQure Appoints Hans Christian Rohde Chief Commercial Officer11
. CIVCO Medical Solutions Appoints Senior Vice President and General Managers to Business Units